Knight Therapeutics Inc
TSX:GUD
Knight Therapeutics Inc
Revenue
Knight Therapeutics Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Revenue
CA$328.2m
|
CAGR 3-Years
18%
|
CAGR 5-Years
92%
|
CAGR 10-Years
N/A
|
Bausch Health Companies Inc
TSX:BHC
|
Revenue
$8.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
Canopy Growth Corp
TSX:WEED
|
Revenue
CA$298.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Cronos Group Inc
TSX:CRON
|
Revenue
$87.2m
|
CAGR 3-Years
23%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Revenue
$2.3B
|
CAGR 3-Years
71%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
T
|
Terrascend Corp
CNSX:TER
|
Revenue
$247.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Knight Therapeutics Inc's Revenue?
Revenue
328.2m
CAD
Based on the financial report for Dec 31, 2023, Knight Therapeutics Inc's Revenue amounts to 328.2m CAD.
What is Knight Therapeutics Inc's Revenue growth rate?
Revenue CAGR 5Y
92%
Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Knight Therapeutics Inc have been 18% over the past three years , 92% over the past five years .